CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 42 enrolled
Drug / intervention
Hand Instrumentation Treatment +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03501316
NCT03501316N/ACompleted

Immune Response After Periodontal Treatment

University of Glasgow·interventional·Posted Apr 18, 2018·Updated Feb 11, 2020

In Brief

A clinical study evaluating Hand Instrumentation Treatment and Ultrasonic Instrumentation Treatment for Periodontal Diseases. Completed, enrolled 42 participants across 1 site.

Detailed Summary

Primary Objective: To identify changes in systemic markers of inflammation following periodontal treatment, comparing two standard treatment modalities (hands scaling and ultrasonic scaling) Secondary Objectives: To investigate bacteraemia, composition and function of oral bacteria, treatment outcomes following periodontal treatment, patient and operator preferences, and treatment time comparing hand scaling and ultrasonic scaling.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedApr 18, 2018
Enrollment StartMay 1, 2018
Primary CompletionAug 1, 2019
Study CompletionSep 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.2 years ago

Interventions

Hand Instrumentation Treatmentdevice

Provision of treatment for periodontal disease using hand instrumentation. Following this, data will be collected relating to various factors, principle of which being systemic immune response.

Ultrasonic Instrumentation Treatmentdevice

Provision of treatment for periodontal disease using ultrasonic instrumentation. Following this, data will be collected relating to various factors, principle of which being systemic immune response.